Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: accountclosed who wrote (56817)	4/21/1999 10:35:00 AM
From: Knighty Tin	Read Replies (1) \| Respond to of 132070

AR, Merck is an odd case. It is a truly great co. As a stock, it is selling at 35 times and growing earnings at 15%. Also, the pipeline looks a bit puny here and I think all drug stocks have more risk than potential right now. Something has to be done to reign in expensive drug prices and whatever it is will not be positive. So, I love Merck and if he is holding for 20 years, it will beat a T-Bond. If he needs the money in five years or less, I would sell.